Does angiotensin-converting enzyme gene polymorphism affect blood pressure? Findings after 6 years of follow-up in healthy subjects

European Journal of Heart Failure

Volumn 6, Issue 1, 2004, Pages 11-16

  Di Pasquale, Pietro ^a   Cannizzaro, Sergio ^a   Paterna, Salvatore ^b  

^a Ospedale GF Ingrassia   (Italy)

^b UNIVERSITY OF PALERMO   (Italy)

Author keywords

ACE I D gene polymorphism; Healthy subjects; Hypertension

Indexed keywords

CHOLESTEROL; DIPEPTIDYL CARBOXYPEPTIDASE;

ADULT; AGED; ARTICLE; BLOOD PRESSURE MONITORING; BLOOD SAMPLING; CARDIOVASCULAR RISK; CLINICAL PROTOCOL; COMPARATIVE STUDY; CONTROLLED STUDY; DATA ANALYSIS; DNA DETERMINATION; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAM; FEMALE; FOLLOW UP; GENETIC POLYMORPHISM; GENOTYPE; HEART MUSCLE ISCHEMIA; HIGH RISK POPULATION; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; INCIDENCE; MALE; NORMAL HUMAN; PATIENT SELECTION; PHYSICAL EXAMINATION; POPULATION RESEARCH; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; SENESCENCE; STATISTICAL SIGNIFICANCE; VENOUS BLOOD;

ADULT; BLOOD PRESSURE; FEMALE; FOLLOW-UP STUDIES; GENE DELETION; GENOTYPE; HUMANS; HYPERTENSION; INCIDENCE; MALE; MIDDLE AGED; MUTAGENESIS, INSERTIONAL; PEPTIDYL-DIPEPTIDASE A; POLYMORPHISM, GENETIC; PROSPECTIVE STUDIES; REFERENCE VALUES; TIME FACTORS;

EID: 0842348050     PISSN: 13889842     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejheart.2003.07.009     Document Type: Article

References (25)

1. Cambien F., Poirer O., Lecerf L., et al. Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction. Nature. 359:1992;641-644.
2. Mattu R.K., Needham E.W., Galton D.J., Frangos E., Clark A.J., Caulfield M. A DNA variant at the angiotensin-converting-enzyme gene locus associates with coronary artery disease in the Carphilly Heart Study. Circulation. 91:1995;270-274.
3. Ludwig E., Corneli P.S., Anderson J.L., Marshall H.W., Laoulel J.M., Ward R.H. Angiotensin-converting enzyme gene polymorphism is associated with myocardial infarction but not with development of coronary stenosis. Circulation. 91:1995;2120-2124.
4. Nakai K., Itoh C., Miura Y., et al. Deletion polymorphism of the angiotensin I-converting-enzyme gene associated with serum ACE-concentration and increased risk for CAD in the Japanese. Circulation. 90:1994;2199-2201.
5. Markus H.S., Barley S., Lunt R., et al. Angiotensin converting enzyme gene polymorphism: a new risk factor for lacunar stroke but not carotid atheroma. Stroke. 126:1996;1329-1333.
6. Margaglione M., Celentano E., Grandone E., et al. Deletion polymorphism in the angiotensin converting enzyme gene in patients with a history of ischemic stroke. Arterioscler Thromb Vasc Biol. 16:1996;304-309.
7. Lindpainter K., Pfeffer M.A., Kreutz R., et al. A prospective evaluation of an angiotensin-converting-enzyme gene polymorphism and the risk of ischemic heart disease. New Engl J Med. 332:1995;706-711.
8. Higaki J., Baba S., Katsuya T., et al. Deletion allele of angiotensin-converting enzyme gene increases risk of essential hypertension in Japanese men. Circulation. 101:2000;2060-2065.
9. O'Donnell C.J., Larson M.G., Lindpainter K., et al. Evidence for association and genetic linkage of the angiotensin-converting enzyme locus with hypertension and blood pressure in men but not women in the Framingham heart study. Circulation. 97:1998;766-772.
10. Schiller N.B., Shah P.M., Crawford M., et al. Recommendations for quantitation on left ventricle by two-dimensional echocardiography: American society of echocardiography committee on standards, subcommittee on quantitation of two-dimensional echocardiograms. J Am Soc Echocardiog. 2:1989;358-367.
11. Sahn D.J., DeMaria A., Kisslo J., Weyman A. Recommendations regarding quantification in M-mode echocardiography; results of a survey of echocardiographic measurements. Circulation. 58:1978;1072-1083.
12. Paterna S., Di Pasquale P., D'Angelo A., et al. Angiotensin-converting enzyme gene deletion polymorphism determines an increase in frequency of migraine attacks in patients suffering from migraine without aura. Eur Neurol. 43:2000;133-136.
13. Prasad A., Narayanan S., Waclawir M.A., Epstein N., Quyyumi A.A. The insertion/deletion polymorphism of the angiotensin converting enzyme gene determines coronary vascular tone and nitric oxide activity. J Am Coll Cardiol. 36:2000;1579-1586.
14. Butler R., Morris A.D., Burchell B., Struthers A.D. DD angiotensin-converting enzyme polymorphism is associated with endothelial dysfunction in normal humans. Hypertension. 33:1999;1164-1168.
15. Montgomery H.E., Kierman L.A., Whilworth C.E., et al. Inhibition of tissue angiotensin converting enzyme activity prevents malignant hypertension in TGRmRen2-27. J Hypertens. 16:1998;635-643.
16. Majer N.J., Forsyth A., Kantachuvesiri S., Mullins J.J., Fleming S. Association of the D allele of the angiotensin I converting enzyme polymorphism with malignant vascular injury. J Clin Pathol Mol Pathol. 55:2002;29-33.
17. Kamitani A., Rakugi H., Higaki J., et al. Association analysis of a polymorphism of the angiotensinogen gene with essential hypertension in Japanese. J Hum Hypertens. 8:1994;521-524.
18. Jeunemaitre X., Lifton R.P., Hunt S.C., Williams R.R., Lalouel J.M. Absence of linkage between the angiotensin converting enzyme locus and human essential hypertension. Nat Genet. 1:1992;72-75.
19. Schmidt S., Van Hocft I.M., Grobbee D.E., et al. Polymorphism of the angiotensin I converting enzyme is apparently not related to high blood pressure. Dutch hypertension and offsprings study. J Hypertens. 11:1993;345-348.
20. Rigat B., Hubert C., Alhenc-Gelas F., et al. An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest. 86:1990;1343-1346.
21. Tiret L., Rigat B., Visvikis S., et al. Evidence from combined segregation and linkage analysis, that a variant of the angiotensin I-converting enzyme (ACE) gene controls plasma ACE levels. Am J Hum Genet. 51:1992;197-205.
22. Donser A.H., Sachalekamp M.A., Box W.A., et al. Angiotensin converting enzyme in the human heart. Effect of the deletion/insertion polymorphism. Circulation. 92:1995;1387-1388.
23. Busjahn A., Knoblauch H., Knoblauch M., et al. Angiotensin converting enzyme and angiotensinogen gene polymorphisms, plasma levels, cardiac dimension: a twin study. Hypertension. 29:1997;65-70.
24. Gibbons G.H., Dzau V.J. The emerging concept of vascular remodelling. New Engl J Med. 330:1994;431-438.
25. Marishita R., Higaki J., Miyazaki M., et al. Possible role of the vascular renin-angiotensin system in hypertension and vascular hypertrophy. Hypertension. 19:1992;II62-II67.